iBio, Inc. (IBIO): Price and Financial Metrics

IBIO POWR Grades

• Momentum is the dimension where IBIO ranks best; there it ranks ahead of 41.53% of US stocks.
• The strongest trend for IBIO is in Growth, which has been heading up over the past 179 days.
• IBIO ranks lowest in Quality; there it ranks in the 1st percentile.

IBIO Stock Summary

• IBIO's price/sales ratio is 62.29; that's higher than the P/S ratio of 96.69% of US stocks.
• As for revenue growth, note that IBIO's revenue has grown -29.86% over the past 12 months; that beats the revenue growth of only 5.6% of US companies in our set.
• The volatility of iBio Inc's share price is greater than that of 95.09% US stocks with at least 200 days of trading history.
• If you're looking for stocks that are quantitatively similar to iBio Inc, a group of peers worth examining would be BDR, MBII, RNLX, APPN, and DIOD.
• IBIO's SEC filings can be seen here. And to visit iBio Inc's official web site, go to www.ibioinc.com.

IBIO Valuation Summary

• In comparison to the median Healthcare stock, IBIO's price/sales ratio is 2326.32% higher, now standing at 92.2.
• IBIO's price/sales ratio has moved up 59.3 over the prior 144 months.
• IBIO's price/sales ratio has moved up 59.3 over the prior 144 months.

Below are key valuation metrics over time for IBIO.

IBIO Growth Metrics

Its 3 year net cashflow from operations growth rate is now at -100.68%.
• The 2 year revenue growth rate now stands at 162.6%.
• Its 4 year price growth rate is now at -78.31%.

Over the past 55 months, IBIO's revenue has gone up $1,241,000.

The table below shows IBIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1.635	-34.608	-28.621
2021-09-30	2.172	-32.341	-24.873
2021-06-30	2.371	-30.064	-23.467
2021-03-31	3	-26.705	-27.121
2020-12-31	2.331	-23.142	-24.137
2020-09-30	1.94	-18.128	-41.33

IBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• IBIO has a Quality Grade of D, ranking ahead of 5.38% of graded US stocks.
• IBIO's asset turnover comes in at 0.017 -- ranking 375th of 681 Pharmaceutical Products stocks.
• COLL, COCP, and IRWD are the stocks whose asset turnover ratios are most correlated with IBIO.

The table below shows IBIO's key quality metrics over time.